Sequential administration of XPO1 and ATR inhibitors enhances therapeutic response in TP53-mutated colorectal cancer.
暂无分享，去创建一个
G. Genovese | C. Bristow | S. Seth | S. Kopetz | T. Heffernan | G. Draetta | Ningping Feng | T. Kodama | R. Minelli | J. Roszik | K. Akdemir | Yonathan Lissanu Deribe | A. Viale | T. Khor | M. Peoples | D. Menter | A. Inoue | Angela Deem | Johnathon L. Rose | Sanjana Srinivasan | J. Daniele | A. Carugo | A. Harris | Xiaoyan Ma | Bahar Salimian Rizi | V. Giuliani | David Brunell | T. Shingu | Hideo Tomihara | C. Stephan | Mary Sobieski | S. Loponte | R. Mullinax | Frederick S. Robinson | Andy M. Zuniga | Robert A. Mullinax | Y. L. Deribe | Virginia Giuliani